Therapy of hematopoietic disorders with recombinant colony-stimulating factors

Therapy-related myelodysplastic syndromes deserve specific diagnostic sub-classification and risk-stratification-an approach to classification of patients with t-MDS.

Leukemia·2020

Granulocyte-monocyte and Granulocyte-Colony Stimulating Factors in Myelodysplastic Syndromes.

Leukemia & lymphoma·2016

Allogeneic hematopoietic cell transplantation after failed autologous transplant for lymphoma using TLI and anti-thymocyte globulin conditioning.

Bone marrow transplantation·2015

Validation of WHO classification-based Prognostic Scoring System (WPSS) for myelodysplastic syndromes and comparison with the revised International Prognostic Scoring System (IPSS-R). A study of the International Working Group for Prognosis in Myelodysplasia (IWG-PM).

Leukemia·2015

Molecular and genetic features of myelodysplastic syndromes.

International journal of laboratory hematology·2012

Tandem chemo-mobilization followed by high-dose melphalan and carmustine with single autologous hematopoietic cell transplantation for multiple myeloma.

Bone marrow transplantation·2011

T Cell subsets for therapy-unconventional CD1d-restricted natural killer T cells.

Advances in pharmacology (San Diego, Calif.)·2026

Tracking therapeutic T cells in vivo.

Advances in pharmacology (San Diego, Calif.)·2026

In vivo transduction of CAR T cells: Pharmacological principles, delivery platforms, and the road to clinical translation.

Advances in pharmacology (San Diego, Calif.)·2026

Transient T cell therapies.

Advances in pharmacology (San Diego, Calif.)·2026

Manufacturing as biology: How T-cell processing shapes therapeutic outcomes.

Advances in pharmacology (San Diego, Calif.)·2026

Engineering T cell metabolism to enhance therapeutic efficacy.

Advances in pharmacology (San Diego, Calif.)·2026

Serum hepcidin and erythropoietin in relation to anemia in non-diabetic chronic kidney disease: a cross-sectional study.

Scientific reports·2026

After-Hours Surgery Is Associated With Adverse Perioperative Outcomes Following Hemiarthroplasty for Femoral Neck Fracture.

The Journal of arthroplasty·2026

Age-Stratified Conditioning Regimens for Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Myelodysplastic Syndromes: A Comprehensive Review.

Hematological oncology·2026

Impact of Shexiang Baoxin Pill (MUSKARDIA) on Cardiovascular Outcomes by Baseline Hemoglobin Levels in 2,494 Patients with Chronic Stable Coronary Artery Disease: A Secondary Subgroup Analysis.

Chinese journal of integrative medicine·2026

Occult meningeal arterial bleeding in recurrent and postoperative subdural hemorrhage: implications for surgical decision-making and adjunctive middle meningeal artery embolization.

Neurosurgical review·2026

Relationship Between the Systemic Coagulation-Inflammation Index and Radial Artery Occlusion After Transradial Coronary Angiography.

Cardiology research·2026

Related Experiment Videos

Therapy of hematopoietic disorders with recombinant colony-stimulating factors

Related Concept Videos

Therapy-related myelodysplastic syndromes deserve specific diagnostic sub-classification and risk-stratification-an approach to classification of patients with t-MDS.

Granulocyte-monocyte and Granulocyte-Colony Stimulating Factors in Myelodysplastic Syndromes.

Allogeneic hematopoietic cell transplantation after failed autologous transplant for lymphoma using TLI and anti-thymocyte globulin conditioning.

Validation of WHO classification-based Prognostic Scoring System (WPSS) for myelodysplastic syndromes and comparison with the revised International Prognostic Scoring System (IPSS-R). A study of the International Working Group for Prognosis in Myelodysplasia (IWG-PM).

Molecular and genetic features of myelodysplastic syndromes.

Tandem chemo-mobilization followed by high-dose melphalan and carmustine with single autologous hematopoietic cell transplantation for multiple myeloma.

T Cell subsets for therapy-unconventional CD1d-restricted natural killer T cells.

Tracking therapeutic T cells in vivo.

In vivo transduction of CAR T cells: Pharmacological principles, delivery platforms, and the road to clinical translation.

Transient T cell therapies.

Manufacturing as biology: How T-cell processing shapes therapeutic outcomes.

Engineering T cell metabolism to enhance therapeutic efficacy.

Serum hepcidin and erythropoietin in relation to anemia in non-diabetic chronic kidney disease: a cross-sectional study.

After-Hours Surgery Is Associated With Adverse Perioperative Outcomes Following Hemiarthroplasty for Femoral Neck Fracture.

Age-Stratified Conditioning Regimens for Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Myelodysplastic Syndromes: A Comprehensive Review.

Impact of Shexiang Baoxin Pill (MUSKARDIA) on Cardiovascular Outcomes by Baseline Hemoglobin Levels in 2,494 Patients with Chronic Stable Coronary Artery Disease: A Secondary Subgroup Analysis.

Occult meningeal arterial bleeding in recurrent and postoperative subdural hemorrhage: implications for surgical decision-making and adjunctive middle meningeal artery embolization.

Relationship Between the Systemic Coagulation-Inflammation Index and Radial Artery Occlusion After Transradial Coronary Angiography.

Related Experiment Videos

Therapy of hematopoietic disorders with recombinant colony-stimulating factors

Related Concept Videos

Related Articles